Alirocumab

Alirocumab
Alirocumab is a human monoclonal antibody that inhibits PCSK9. It is produced by recombinant DNA technology in Chinese hamster ovary cell suspension culture.
[accordions]
[accordion title= “Chemical Properties“]
Molecular Weight 146 kDa
CAS No. 1245916-14-6

[/accordion]

 

[accordions]
[accordion title= “References and Literature“]

1. Ramanathan A, et al. Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes. PLoS One. 2016 Apr 26;11(4):e0154498.

[/accordion]